- 
      You can invest up to 10,000 of your 100,000 credits in each question.
 - 
      Now please select the likeliest answer and invest.
- 1,000 credits say "Maybe"
 - 5,000 is "Probably"
 - 10,000 signal "I am certain".
 
 
- 
      The more you buy, the higher the price. The next trader must pay even more. Go on.
 - 
      Click the green check-mark to execute the trade.
 
- 
      Deal? The system confirms if your transaction has been executed.
 - 
      Here you can see how many Credits you have invested so far.
 - 
      You can cash out your Credits at any time with the orange "C"-Button.
 
- 
      This is how the question will be judged in the end, when the final outcome becomes known.
 - 
      This is the precise date or end of the period to which the question refers.
 - 
      After reading the judgement rule, please click here.
 
Price trend
TransactionsNo transaction data yet
- 
    Study the background information carefully.
 - 
    Read the background information carefully, before proceeding.
 
Wiki article
EditInfluenza A
Of the four major strains of the influenza virus, A and B cause most human illness and the annual flu epidemics, novel A subtypes can even result in pandemics (e.g. H1N1 for the 1918 flu pandemic) and are responsible for most severe cases and deaths. [1]
The novel vaccine
A new universal vaccine against the influenza A virus was tested successfully on mice and ferrets. It conferred protection against multiple distinct influenza A strains in mice and ferrets. [2]
Phase 1 clinical trial
A Phase 1 clinical trial of a candidate vaccine, BPL-1357 has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety and its ability to prompt immune responses. [3] It is scheduled to complete on 1 March 2023, and will generate evidence for safety and Immunogenicity against various strains. [4]
Sources
- Types of Influenza Viruses. CDC
 - An inactivated multivalent influenza A virus vaccine. Science, 13 July 2022
 - Trial of potential universal flu vaccine opens. NIH, 28 June 2022
 - Safety and Immunogenicity of BPL-1357. ClinicalTrials.gov, 7 July 2022
 
- 
        Offering the reason for your trade may convince other traders to follow your opinion.
 - 
        Click '+' if you agree, or '–' to disagree. You get a credit for every rating you make.
 - 
        For each '+' the author will get +100 credits added to his trading account .
 - 
        If you rate a comment with "-", please reply and state your objection.
 - 
        Now please rate, reply, or write your own comment. Best of luck!